Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood

被引：3
|
作者：
Matsumura, T
Kami, M [1 ]
Saito, T
Sakamaki, H
Hirai, H
机构：
[1] Univ Tokyo, Fac Med, Dept Haematol & Oncol, Bunkyo Ku, Tokyo 1138655, Japan
[2] Tokyo Metropolitan Komagome Hosp, Dept Haematol, Tokyo, Japan
来源：
LANCET | 1999年 / 353卷 / 9154期
关键词：
D O I：
10.1016/S0140-6736(05)76119-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：752 / 752
页数：1
相关论文
共 50 条
  • [41] Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia
    Cavé, H
    ten Bosch, JV
    Suciu, S
    Guidal, C
    Waterkeyn, C
    Otten, J
    Bakkus, M
    Thielemans, K
    Grandchamp, B
    Vilmer, E
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09): : 591 - 598
  • [42] Clinical implication of minimal residual disease in childhood acute lymphoblastic leukemia
    Yokota, S
    Seriu, T
    Nakao, M
    Iwai, T
    Misawa, S
    INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 1998, 5 (2-4): : 231 - 249
  • [43] Key Markers of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia
    Xia, Min
    Zhang, Hong
    Lu, Zhenghua
    Gao, Yuan
    Liao, Xuelian
    Li, Hong
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (06) : 418 - 422
  • [44] Prognostic Value of Next Generation Sequencing in the Evaluation of Minimal Residual Disease in Pediatric Acute Lymphoblastic Leukemia
    Bozhinovkj, Elizabeta Krstevska
    Matevska-Geshkovska, Nadica
    Stojovska, Marija Staninova
    Teov, Bojan
    Jovanovska, Aleksandra
    Kocheva, Svetlana
    Dimovski, Aleksandar
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 584 - 585
  • [45] Prognostic impact of minimal residual disease in childhood acute lymphoblastic leukaemia depends on immunological subtype: results of trial AIEOP-BFM ALL 2000
    Schrappe, M.
    Rizzari, C.
    Mann, G.
    Moericke, A.
    Valsecchi, M. G.
    Zimmerman, M.
    Bartram, C. R.
    Panzer-Gruemayer, R.
    Schrauder, A.
    Cazzaniga, G.
    Flohr, T.
    Parasole, R.
    Reiter, A.
    Ludwig, W. D.
    Lo Nigro, L.
    Basso, G.
    de Rossi, G.
    Barisone, E.
    Niggli, F.
    Gadner, H.
    Conter, V.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 1 - 1
  • [46] Cytogenetic-specific heterogeneity in the kinetics of minimal residual disease (MRD) clearance in childhood acute lymphoblastic leukaemia (ALL)
    Moorman, Anthony V.
    Richards, Sue M.
    Hanock, Jerry P.
    Mitchell, Chris D.
    Vora, Ajay J.
    Harrison, Christine J.
    Goulden, Nick J.
    BLOOD, 2007, 110 (11) : 427A - 427A
  • [47] Development Of Minimal Residual Disease (MRD) Analysis In Childhood Acute Lymphoblastic Leukaemia (ALL) By Next Generation Sequencing (NGS)
    Williamson, Helen
    Mountjoy, Edward
    Shihab, Hashem
    Bartram, Jack
    Hubank, Mike
    Goulden, Nicholas
    Day, Ian
    Roberts, Eileen
    Moppett, John
    Hancock, Jeremy
    BLOOD, 2013, 122 (21)
  • [48] Detection of minimal residual disease in peripheral blood prior to clinical relapse of childhood acute lymphoblastic leukaemia using PCR
    Lal, A
    Kwan, E
    Haber, M
    Norris, MD
    Marshall, GM
    MOLECULAR AND CELLULAR PROBES, 2001, 15 (02) : 99 - 103
  • [49] Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response.
    Foroni, L
    Coyle, LA
    Papaioannou, M
    Yaxley, JC
    Hoffbrand, AV
    BLOOD, 1996, 88 (10) : 293 - 293
  • [50] Prognostic value of minimal residual disease in relapsed childhood ALL.
    Eckert, C
    Biondi, A
    Seeger, K
    Cazzaniga, G
    Hartmann, R
    Proba, J
    D'Aniello, E
    Beyermann, B
    Seifert, G
    Henze, G
    BLOOD, 2000, 96 (11) : 315A - 315A
12345